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The hemolytic, natural isolate P673 was nephropathogenic when tested in a previously described mouse model (van den Bosch et al., 1979) . Curing this strain with actinomycin D resulted in mutants that had lost resistance to tetracycline and/or the ability to produce hemolysin. Concomitant with the loss of hemolysin was the loss of virulence.
Plasmid analysis revealed that hemolysin was coded by a 41 MD plasmid (pCW2), whereas tetracycline resided on a 70 MD plasmid (pCW1).
Reintroduction of hemolysin plasmid DNA into the cured mutant restored its original virulence level. However, this transconjugant harboured a novel plasmid species of 110 MD (pCW3), instead of the original plasmids, pCW1 and pCW2.
From incompatibility experiments and restriction endonuclease analysis we conclude that pCW3 is a cointegrate structure of pCW1 and pCW2. 
Laboratory of Medical Microbiology, University Hospital, Catharijnesinge1101, Utrecht, The Netherlands
Over the last decades, E. eoliinfections have assumed a major role in modern practice of infectious diseases as serious nosocomial complications during therapy of many medical, surgical and pediatric disorders. At present E. coli is the main cause of gram-negative bacteremia in adults. The polysaccharide K-antigen is one of the most important virulence factors in E. coli bacteremia. E. coli strains with K-capsular polysaccharides are relatively resistant to phagocytosis by polymorphonuclear leukocytes in contrast to E. coli strains without K-antigens (Table 1) . This inhibition ofphagocytosis is related to an impaired recognition of the K+ strains by the phagocytes due to ineffective opsonization in 5~ normal human serum. Decreased opsonization of the K+ strains in normal serum is caused by a low rate of complement activation by these strains with subsequent absence of C3 fixation to the cell wall of the bacteria.
For efficient phagocytosis of encapsulated E. coli strains specific capsular antibodies are necessary as was tested with immune rabbit antisera. Specific opsonizing anticapsular antibodies are able to protect mice against a lethal infection with a live encapsulated E. coli strain.
